Loomis Sayles & CO L P Adaptive Biotechnologies Corp Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $7,861 - $10,879	-244 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $558 - $1,016	15 Added 6.55%	244 $10,000
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $10,307 - $14,992	229 New	229 $14,000
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $11 Million - $14.7 Million	-448,637 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$30.31 - $53.51 $3.41 Million - $6.02 Million	112,595 Added 33.51%	448,637 $13.9 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $13.5 Million - $16.2 Million	336,042 New	336,042 $16.2 Million

187

152M

8.4K

56K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $714M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.